New shot shows promise for fatty liver disease in early trial
NCT ID NCT04880031
First seen Jun 24, 2026 · Last updated Jul 09, 2026 · Updated 3 times
Summary
This study tested a drug called BOS-580 (efimosfermin) in 231 obese adults with or at risk for NASH, a serious fatty liver disease. Participants received either the drug or a placebo as a shot under the skin. The main goal was to check safety and side effects. The trial is now complete, and results will help decide if further testing is warranted.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Efimosfermin (also called BOS-580), a drug given as a shot under the skin
- What this could lead to
- If successful, this could point toward a new treatment option for NASH, a liver disease with no approved therapies.
- What could go wrong
- This is an early Phase 2a trial focused on safety, not proof of effectiveness. The results may not lead to a working treatment, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONALCOHOLIC STEATOHEPATITIS (NASH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Accelemed Research
Austin, Texas, 78745, United States
-
Admed Research
Miami, Florida, 33173, United States
-
Advanced Clinical Research
Miami, Florida, 33156, United States
-
Alliance Research Institute
Canoga Park, California, 91304, United States
-
American Research Corporation at Texas Liver Institute
San Antonio, Texas, 78215, United States
-
Apex Mobile Clinical Research
Bellaire, Texas, 77401, United States
-
Arizona Liver Health
Chandler, Arizona, 85224, United States
-
Arizona Liver Health
Peoria, Arizona, 85381, United States
-
Arizona Liver Health
Tucson, Arizona, 85712, United States
-
Ark Clinical Research
Fountain Valley, California, 92708, United States
-
Catalina Research Institute
Montclair, California, 91763, United States
-
Central Research Associates
Birmingham, Alabama, 35205, United States
-
Century Research
Miami, Florida, 33173, United States
-
Charter Research
Orlando, Florida, 32803, United States
-
Coastal Research Institute, LLC
Fayetteville, North Carolina, 28304, United States
-
Covenant Metabolic Specialists - Fort Myers
Fort Myers, Florida, 33912, United States
-
Covenant Metabolic Specialists - Sarasota
Sarasota, Florida, 34240, United States
-
Entrust Clinical Research Center
Kendall, Florida, 33176, United States
-
Evolution Clinical Trials
Hialeah Gardens, Florida, 33016, United States
-
FOMAT Medical Research
Oxnard, California, 93030, United States
-
Fresno Clinical Research Center
Fresno, California, 92720, United States
-
G+C Research Group
Miami, Florida, 33126, United States
-
Galenus Group
Lehigh Acres, Florida, 33976, United States
-
Houston Research Institute
Houston, Texas, 77079, United States
-
Inland Empire Clinical Trials
Rialto, California, 92377, United States
-
Kansas City Research Institute
Kansas City, Missouri, 64131, United States
-
Knowledge Research Center
Orange, California, 92868, United States
-
Lillestol Research LLC
Fargo, North Dakota, 58104, United States
-
LinQ Research, LLC
Pearland, Texas, 77584, United States
-
Liver Institute NorthWest
Seattle, Washington, 98105, United States
-
Liver Institute PPLC
Tucson, Arizona, 85712, United States
-
Miami Clinical Research
Miami, Florida, 33155, United States
-
Olympus Family Medicine
Salt Lake City, Utah, 84117, United States
-
Panex Clinical Research
Miami Lakes, Florida, 33014, United States
-
Pinnacle Clinical Research - Austin
Austin, Texas, 78757, United States
-
Pinnacle Clinical Research - Georgetown
Georgetown, Texas, 78626, United States
-
Pinnacle Clinical Research - San Antonio
San Antonio, Texas, 78229, United States
-
Progressive Medical Research
Port Orange, Florida, 32127, United States
-
QLMC
Tucson, Arizona, 85712, United States
-
Quality Research, Inc
San Antonio, Texas, 78209, United States
-
South Ogden Family Medicine
South Ogden, Utah, 84405, United States
-
South Texas Research Institute-Brownsville
Brownsville, Texas, 78520, United States
-
South Texas Research Institute-Edinburg
Edinburg, Texas, 75839, United States
-
Southwest General Healthcare Center
Fort Myers, Florida, 33907, United States
-
Tandem Clinical Research
Marrero, Louisiana, 70072, United States
-
Texas Liver Institute - Austin
Austin, Texas, 78757, United States
-
Velocity Clinical Research
East Greenwich, Rhode Island, 02818, United States
-
Velocity Clinical Research - Waco
Waco, Texas, 76710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single pill tackle both fatty liver and diabetes?
- New drug miricorilant tested for fatty liver disease safety
- New drug aramchol aims to reverse fatty liver damage in phase 3 trial
- New drug shows promise against fatty liver disease in Mid-Stage trial
- New drug aims to shrink fatty liver in early trial
- New drug aims to melt liver fat in NASH patients